share_log

Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying

Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying

Neuronetics和其他3只股票的內部人士正在購買
Benzinga ·  06/07 19:48

The Dow Jones index closed higher by around 80 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週四收漲約80點。當內部人員購買或出售股票時，這表明他們對公司前景的信心或擔憂。對於有興趣投資或交易低價股的投資者和交易者來說，這可以考慮爲他們整體投資或交易決策的因素之一。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是幾個近期關於低價股的值得關注的內部交易。了解更多，請查看Benzinga內幕交易平台。

PodcastOne

PodcastOne

  • The Trade: PodcastOne, Inc. (NASDAQ:PODC) Director D Jonathan Merriman bought a total of 42,000 shares at an average price of $1.95. To acquire these shares, it cost around $81,700.
  • What's Happening: On June 6, Litchfield Hills analyst Barry Sine initiated coverage on PodcastOne with a Buy rating and announced a price target of $5.
  • What PodcastOne Does: PodcastOne Inc formerly CourtSide Group Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
  • 交易：PodcastOne, Inc.(納斯達克股票代碼：PODC)的董事D Jonathan Merriman以平均價格1.95美元購買了總共42000股的股票。購買這些股票的成本約爲81700美元。
  • 正在發生：6月6日，Litchfield Hills分析師Barry Sine對PodcastOne進行了買入評級，並公佈了5美元的目標股價。
  • PodcastOne Inc，前身爲CourtSide Group Inc，是一個播客平台和出版商，通過所有播客分發平台，包括其網站、其PodcastOne應用程序、Apple Podcasts、Spotify、Amazon Music等，將其內容提供給觀衆。

Assertio Holdings

assertio

  • The Trade: Assertio Holdings, Inc. (NASDAQ:ASRT) Director, Interim Executive Officer Heather L Mason acquired a total of 25,000 shares at an average price of $0.97. To acquire these shares, it cost around $24,250.
  • What's Happening: On June 6, Assertio Holdings reported inducement grants under NASDAQ Listing Rule 5635(c)(4).
  • What Assertio Holdings Does: Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines.
  • 交易：Assertio Holdings, Inc. (納斯達克股票代碼：ASRT) 的董事、臨時執行官Heather L Mason以平均價格0.97美元購買了總共25000股的股票。購買這些股票的成本約爲24250美元。
  • 正在發生：6月6日，Assertio Holdings根據納斯達克列示規則5635(c)(4)報告了誘因授予。
  • Assertio Holdings Inc是一家制藥公司，致力於提供神經學、孤兒藥和特殊藥物領域的患者護理方案。

BigBear.ai Holdings

BigBear.ai Holdings

  • The Trade: BigBear.ai Holdings, Inc. (NYSE:BBAI) Director Pamela Joyce Braden acquired a total of 140,939 shares at an average price of $1.49. The insider spent around $209,999 to buy those shares.
  • What's Happening: On May 2, BigBear.ai reported worse-than-expected first-quarter financial results.
  • What BigBear.ai Holdings Does: BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers.
  • 交易：BigBear.ai Holdings, Inc. (紐約證券交易所股票代碼：BBAI)的董事Pamela Joyce Braden以平均價格1.49美元購買了總共140939股的股票。內部人員花費約209,999美元購買這些股票。
  • 正在發生：5月2日，BigBear.ai報告了首季度的財務業績低於預期。
  • BigBear.ai Holdings Inc是一家技術領先的解決方案組織，爲其客戶提供軟件和服務。

Neuronetics

neuronetics

  • The Trade: Neuronetics, Inc. (NASDAQ:STIM) Director Robert Cascella acquired a total of 50,000 shares at an average price of $2.05. The insider spent around $102,550 to buy those shares.
  • What's Happening: On May 7, Neuronetics reported first-quarter financial results and issued second-quarter revenue guidance below estimates.
  • What Neuronetics Does: Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
  • 交易：Neuronetics, Inc. (納斯達克股票代碼：STIM)的董事Robert Cascella以平均價格2.05美元購買了總共50000股的股票。內部人員花費約102550美元購買這些股票。
  • 正在發生：5月7日，Neuronetics報告了第一季度的財務業績，併發布了低於預期的第二季度營業收入指引。
  • Neuronetics Inc是一家商業化階段的醫療技術公司，專注於設計、開發和營銷改善患者精神障礙患者生活質量的產品。

Don't forget to check out our premarket coverage here

別忘了查看我們的盤前報道。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論